(Q71727280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

1 reference

1 reference

C J Verdi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H S Garewal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

L M Koenig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

B Vaughn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

T Burkhead

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

36-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin. A phase I-II study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Proto-chemotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2895%2980014-X

7 January 2021

10.1016/S1079-2104(95)80014-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552860%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference